Explore tweets tagged as #generics
After 20 years of R&D, China’s biotech industry is accelerating medicine production while cutting costs,delivering affordable drugs, including cancer treatments, to millions worldwide. Using CRISPR and advanced tech, it’s moving beyond generics to breakthrough therapies. During
0
2
2
Pharma sector faces volatile quarter two amid GST impact and weak US generics Read More at: https://t.co/SpJ8c8h20F
0
0
2
Cheryl with Nivea, Nicola with Aveeno and Nadine with Skin Generics... Please Kimberley have a skincare endorsement such as Celeteque or Neutrogena 🤞
1
6
55
0
1
3
$SBFM is about to pull a monster squeeze 🚀🚀🚀🚀 https://t.co/aPVNypKTq7
1
2
4
Immerse yourself in the dynamic world of generics, biosimilars, and value-added medicines! Check out our infographic preview of Generics Bulletin’s Top 50 2025: https://t.co/TPhAZtaPyK
0
0
0
When a pill changes color or shape, patients are 34-66% more likely to stop taking their meds. Patient experience drives adherence, and adherence impacts effectiveness. Explore how patient-centric formulations are the new competitive advantage in generics: https://t.co/jNDh1cNINk
0
0
2
new gophers after finding out it doesn't have min/max for generics
2
0
25
#BlogAlert India’s #pharma & #medtech sector is evolving from generics to innovation with the Promotion of Research and Innovation in Pharma MedTech (#PRIP) scheme, boosting R&D and global #investment. Discover India's rise in healthcare: https://t.co/7O95vfB9CN
#InvestInIndia
1
3
9
More TypeScript prompts just landed on DevPromptly 🚀 From utility types to generics, prompts to make your typing smoother. 👉 https://t.co/t9LH2s8CSl
#typescript #Devs #prompt
0
2
3
Healthcare is evolving, and @CosmosHealthInc is leading the merge of wellness and Web3. Through $COSM, they’re building a new kind of healthcare ecosystem: one rooted in transparency, sustainability, and blockchain verification. From nutraceuticals to branded generics, Cosmos is
0
1
30
The $TEVA narrative has flipped. This is no longer just a generics deleveraging story. It's a neuroscience growth story trading at ~7x forward earnings. The smart money is moving in. We just saw 35,000 contracts of the Oct 2025 $21 calls get scooped up. The catalyst?
1
2
16
Pharma 💊 Sector makes a long term bottom when it becomes an avoid for general public due to tariff news ~Genrics have more than 95% share in Pharma exports to US ~US meets more than 50% of generics requirements from India only Generics are imp to keep the drug prices low
12
6
71
For comparison, here are some typical prices of insulin pens (though generics can be gotten for $55 per pen): Insulin Aspart Flexpen, $90; Novolog pen, $130; Humalog, $129 per pen; Xultophy, $314 per pen; Fiasp, $771 per pen. Leadership that prioritizes people. #CaliforniaCares
Breaking: Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Newsom announced today. Long-acting insulin pens will be available at pharmacies for $11 per pen beginning Jan. 1. https://t.co/8EU9BYAVyJ
0
3
4